Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Wisniewski, Jessica | - |
| dc.date.accessioned | 2026-06-02T20:47:40Z | - |
| dc.date.available | 2026-06-02T20:47:40Z | - |
| dc.date.issued | 2021 | - |
| dc.identifier.issn | 2691-9729 | - |
| dc.identifier.uri | http://hdl.handle.net/2451/75747 | - |
| dc.description.abstract | In many ways, the Egyptian and Israeli states fail to ‘see’ the Bedouin and therefore situate them as a group “in but not of the global order,” an order where nations and states represent contingent identities and socio-political organizations. However, the Bedouin are not legally recognized as a distinct nation nor as indigenous peoples in neither Egypt nor Israel, and Egyptian Nationalism and Zionism reject the Bedouin as part of their nation, or ‘imagined community.’ This concept of nationalism strongly influences policy, and as a result, leads to the discrimination of the Bedouin through internal colonial policies, land seizure, suspension of human rights, and exclusionary economic policy. Despite Egypt and Israel’s different political systems, the outcome for the Bedouin in both countries is remarkably similar. | - |
| dc.publisher | NYU Global Liberal Studies | - |
| dc.rights | The author(s) hold the copyright in the manuscript and have the right to grant a license to publish their work. They retain all rights to the work and grant NYU, on behalf of The Interdependent, a nonexclusive, royalty free, irrevocable license to publish the manuscript in both print and digital form. | - |
| dc.subject | Bedouin, Egypt, Israel, Nationalism, Zionism, Economic Exclusion, Negev Desert, Sinai Peninsula, Hapoel Hatzair, Yosef Aharonovich | - |
| dc.title | Identity and Nation: Comparing Egyptian and Israeli Bedouin Policy | - |
| dc.type | article | - |
| dc.identifier.DOI | https://doi.org/10.33682/27b9-hcfc | - |
| Appears in Collections: | The Interdependent, Volume 2 Fall 2021 | |
Files in This Item:
There are no files associated with this item.
Items in FDA are protected by copyright, with all rights reserved, unless otherwise indicated.